Zimmer Biomet Holdings (ZBH) EBT (2009 - 2026)

Zimmer Biomet Holdings has reported EBT for 18 years, with the latest figure at $255.1 million in Q2 2026.

• On a quarterly basis, EBT rose 13.58% year-over-year to $255.1 million in Q2 2026; TTM through Jun 2026 was $1.1 billion, a 9.07% increase from a year earlier, with the FY2025 full-year figure at $958.3 million, down 7.55% from the prior year.
• EBT was $255.1 million for Q2 2026 at Zimmer Biomet Holdings, down from $301.3 million in the prior quarter.
• The five-year high for EBT was $302.2 million in Q2 2024, with the low at $101.2 million in Q1 2022.
• Average EBT over 5 years is $236.9 million, with a median of $229.6 million recorded in 2024.
• The largest YoY upside for EBT was 380.23% in 2022 against a maximum downside of 52.73% in 2022.
• Over 5 years, EBT stood at $167.6 million in 2022, then soared by 69.75% to $284.5 million in 2023, then increased by 1.58% to $289.0 million in 2024, then dropped by 21.97% to $225.5 million in 2025, then climbed by 13.13% to $255.1 million in 2026.
• The last three EBT figures came in at $255.1 million (Q2 2026), $301.3 million (Q1 2026), and $225.5 million (Q4 2025), per Business Quant data.